Key result
The low-dose STZ and high-fat diet experimental model replicated mitochondrial changes seen in diabetes, including decreased mitochondria area, increased complex-III and complex-V protein abundance, and reduced complex-II oxygen consumption.
Why the study?
Mitochondrial dysfunction and excess ROS are common in the diabetic heart, but mitochondrial structural and functional impairments in a recently described mouse model of diabetic cardiomyopathy required characterisation.
The low-dose STZ and high-fat diet murine model successfully replicates key mitochondrial structural and functional changes seen in diabetic cardiomyopathy, providing a useful platform for testing mitochondria-targeted therapies.
Answers are grounded in this paper and cite their sources.
This murine model replicates select mitochondrial changes in diabetic cardiomyopathy; leaves open clinical translation of targeted therapies.
People affected by diabetes are at an increased risk of developing heart failure than their non-diabetic counterparts, attributed in part to a distinct cardiac pathology termed diabetic cardiomyopathy. Mitochondrial dysfunction and excess reactive oxygen species (ROS) have been implicated in a range of diabetic complications and are a common feature of the diabetic heart. In this study, we sought to characterise impairments in mitochondrial structure and function in a recently described experimental mouse model of diabetic cardiomyopathy. Diabetes was induced in 6-week-old male FVB/N mice by the combination of three consecutive-daily injections of low-dose streptozotocin (STZ, each 55 mg/kg i.p.) and high-fat diet (42% fat from lipids) for 26 weeks. At study end, diabetic mice exhibited elevated blood glucose levels and impaired glucose tolerance, together with increases in both body weight gain and fat mass, replicating several aspects of human type 2 diabetes. The myocardial phenotype of diabetic mice included increased myocardial fibrosis and left ventricular (LV) diastolic dysfunction. Elevated LV superoxide levels were also evident. Diabetic mice exhibited a spectrum of LV mitochondrial changes, including decreased mitochondria area, increased levels of mitochondrial complex-III and complex-V protein abundance, and reduced complex-II oxygen consumption. In conclusion, these data suggest that the low-dose STZ-high fat experimental model replicates some of the mitochondrial changes seen in diabetes, and as such, this model may be useful to study treatments that target the mitochondria in diabetes.
No takes yet. Share an insight, caveat, or question.
Parker et al. (2021) studied Diabetic Cardiomyopathy. Low-dose streptozotocin and high-fat diet vs. Citrate vehicle and standard laboratory chow was evaluated on Myocardial mitochondria structural and functional phenotype (including LV diastolic dysfunction, ROS levels, and mitochondrial respiration). The low-dose STZ and high-fat diet experimental model replicated mitochondrial changes seen in diabetes, including decreased mitochondria area, increased complex-III and complex-V protein abundance, and reduced complex-II oxygen consumption.
Synapse has enriched 10 related papers. Consider them for comparative context: